Disclosures for "Clinical, MRI, RT-QuIC, and 18FDG-PET Correlates in Patients with Sporadic CJD "
-
Ms. Jaramillo has nothing to disclose.
-
Dr. Sadaghiani has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
-
Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.